Skip to content

To access the new portal/member content, please reset your username and password by clicking "I forgot my login name or password" on this page.

Pediatric Endocrine Society
  • Clinical
    Resources
    • Clinical Resource Library
    • Referral Guidelines
    • Special Interest Groups
    • Online Community
    • Insurance Appeal Letter Templates
    • And the survey says…
  • Patient
    Resources
    • What is a Pediatric Endocrinologist?
    • Patient Education
      • Patient Education Videos
    • Find a Pediatric Endocrinologist
    • Camps
    • Clinical Studies
    • Transition Toolkit
  • Education
    & Events
    • PES 50th Anniversary
    • Events Calendar
    • PES 2023 Annual Meeting
    • Board Review Course
    • Online Education
    • PES Leadership Advantage (PESLA)
    • Mentor Match Program
    • Fellows, Residents, and Students
      • PedsENDO365
      • PedsENDO Discovery Program
      • Practical Clinical Tools
      • Clinical Update and Case Discussion Course
      • Spring Fellows Retreat
      • ESPE E-Learning Web Portal
      • Mentoring Program
      • SEED
  • News &
    Publications
    • PES News & Announcements
    • Journal
  • Careers
    • Job Board
    • Pediatric Endocrine Program Directors
    • Certification
      • Maintenance of Certification (MOC)
      • Ethics in Pediatric Endocrinology MOC
      • PES Obesity SIG MOC/CME Activity
      • Precocious Puberty Self-Assessment MOC/CME
  • Grants
    & Awards
    • Senior Awards and Lectureships
    • Fellows and Junior Faculty Awards
    • Grants
  • About
    PES
    • About PES
      • Contact
      • Leadership
      • PES Committees
      • Society History
    • PES Membership
      • Join PES
    • Partner with Us
      • Mission Alliance Partners
      • Become a Mission Alliance Partner
      • PES Mission Alliance Partner Spotlight
      • Exhibit & Sponsorship Opportunities
      • Mailing List and Advertising
      • Conflict of Interest Statement
    • Policies and Strategy
      • Equity, Diversity and Inclusion Initiative
      • Strategic Plan
      • Policies and Bylaws
      • Public Policy and Advocacy
  • Join PES
  • Contact
  • Find a Pediatric Endocrinologist
  • Join PES
  • Contact
  • Find a Pediatric Endocrinologist
Pediatric Endocrine Society
Member Login
  • Clinical
    Resources
    • Clinical Resource Library
    • Referral Guidelines
    • Special Interest Groups
    • Online Community
    • Insurance Appeal Letter Templates
    • And the survey says…
  • Patient
    Resources
    • What is a Pediatric Endocrinologist?
    • Patient Education
      • Patient Education Videos
    • Find a Pediatric Endocrinologist
    • Camps
    • Clinical Studies
    • Transition Toolkit
  • Education
    & Events
    • PES 50th Anniversary
    • Events Calendar
    • PES 2023 Annual Meeting
    • Board Review Course
    • Online Education
    • PES Leadership Advantage (PESLA)
    • Mentor Match Program
    • Fellows, Residents, and Students
      • PedsENDO365
      • PedsENDO Discovery Program
      • Practical Clinical Tools
      • Clinical Update and Case Discussion Course
      • Spring Fellows Retreat
      • ESPE E-Learning Web Portal
      • Mentoring Program
      • SEED
  • News &
    Publications
    • PES News & Announcements
    • Journal
  • Careers
    • Job Board
    • Pediatric Endocrine Program Directors
    • Certification
      • Maintenance of Certification (MOC)
      • Ethics in Pediatric Endocrinology MOC
      • PES Obesity SIG MOC/CME Activity
      • Precocious Puberty Self-Assessment MOC/CME
  • Grants
    & Awards
    • Senior Awards and Lectureships
    • Fellows and Junior Faculty Awards
    • Grants
  • About
    PES
    • About PES
      • Contact
      • Leadership
      • PES Committees
      • Society History
    • PES Membership
      • Join PES
    • Partner with Us
      • Mission Alliance Partners
      • Become a Mission Alliance Partner
      • PES Mission Alliance Partner Spotlight
      • Exhibit & Sponsorship Opportunities
      • Mailing List and Advertising
      • Conflict of Interest Statement
    • Policies and Strategy
      • Equity, Diversity and Inclusion Initiative
      • Strategic Plan
      • Policies and Bylaws
      • Public Policy and Advocacy
  • Join PES
  • Contact
  • Find a Pediatric Endocrinologist
March 21, 2017

Kaiser Health News Report on GnRH

Media Release: Updated Information About Safety Events after Gonadotropin Releasing Hormone Agonist Therapy.

3/21/17

Dear Colleagues,

On 2/2/17, Kaiser Health News published an article raising concerns about potential long-term side effects of leuprolide acetate for depot suspension in women previously treated with this medication. In the article, it was reported that the FDA issued the following statement: “We are currently conducting a specific review of nervous system and psychiatric events in association with the use of GnRH agonists, [a class of drugs] including Lupron, in pediatric patients.”

On 2/9/17, we issued the following statement: “At this time, we are not aware of any new documented safety concerns with this class of drugs that should change prescribing practices or warrant discontinuation of these medications.” Since that time, members of our committee, with the assistance of other PES members, have investigated these safety issues further. We have conducted a literature search and contacted the manufacturers of GnRH agonists in the U.S. and pediatric endocrinology colleagues in the US, UK, EU and South America to inquire about any new safety issues. These queries have identified no safety concerns that are not currently reflected in the product labels.

We have also spoken with our colleagues at the Food and Drug Administration who acknowledge that a Tracked Safety Issue (TSI) has been initiated for review of potential safety concerns in this class of medications. The FDA collects information about adverse events via the FDA Adverse Event Reporting System (FAERS). TSIs are generated when a safety review is undertaken for potential safety concerns that are not considered urgent. The TSI review process is expected to take 6-12 months.

After further review of available information, we do not feel that there is any new safety concern with GnRH agonists that should change our prescribing practices at this time.

As always, for any of the medications prescribed by pediatric endocrinologists, we encourage our colleagues to report to the FDA any unexpected adverse events that may be related to use of these medications. In aggregate, these reports serve as a key source of information for FDA inquiries and are critical to identify post-marketing safety issues. Reports can be completed online at: https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reporting.home

We will update you as further information becomes available.

Sincerely,

Bradley S. Miller, MD, PhD and Takara Stanley, MD

On Behalf of the Drug & Therapeutics Committee

Pediatric Endocrine Society

Posted in Public Policy
Share this

Recent Posts

  • March 2023 President’s Letter
  • Historical Tidbit: Philip Showalter Hench, MD (February 28, 1896-March 30, 1965)
  • March Fellow Spotlight – Annie Gladding
  • March APP Spotlight – Kim Clash, CPNP
  • New Meds and Tech from the PES Drugs and Therapeutics committee: Dexcom G7

Categories

  • APP Spotlight
  • Drug Alerts/Recalls
  • Drug Shortages
  • Fellow Spotlight
  • Fellowship Posting
  • Historical Tidbits
  • In Memoriam
  • Member Spotlight
  • New Meds and Tech
  • News & Announcements
  • Oral History
  • PES Leadership Advantage
  • pm-pearls
  • President's Message
  • Public Policy
  • Student Spotlight
  • Uncategorized

Get Involved

Join a Special Interest Group

Learn More

Join PES

Learn More

Mentoring Program

Learn More

Explore PES Grants & Scholarships

Learn More

pes-white-logo

6728 Old McLean Village Dr
McLean, Virginia 22101
Phone: (703) 884-9781
info@pedsendo.org

  • Clinical
    Resources
    • Clinical Resource Library
    • Referral Guidelines
    • Special Interest Groups
    • Online Community
    • Insurance Appeal Letter Templates
    • And the survey says…
  • Patient
    Resources
    • What is a Pediatric Endocrinologist?
    • Patient Education
      • Patient Education Videos
    • Find a Pediatric Endocrinologist
    • Camps
    • Clinical Studies
    • Transition Toolkit
  • Education
    & Events
    • PES 50th Anniversary
    • Events Calendar
    • PES 2023 Annual Meeting
    • Board Review Course
    • Online Education
    • PES Leadership Advantage (PESLA)
    • Mentor Match Program
    • Fellows, Residents, and Students
      • PedsENDO365
      • PedsENDO Discovery Program
      • Practical Clinical Tools
      • Clinical Update and Case Discussion Course
      • Spring Fellows Retreat
      • ESPE E-Learning Web Portal
      • Mentoring Program
      • SEED
  • News &
    Publications
    • PES News & Announcements
    • Journal
  • Careers
    • Job Board
    • Pediatric Endocrine Program Directors
    • Certification
      • Maintenance of Certification (MOC)
      • Ethics in Pediatric Endocrinology MOC
      • PES Obesity SIG MOC/CME Activity
      • Precocious Puberty Self-Assessment MOC/CME
  • Grants
    & Awards
    • Senior Awards and Lectureships
    • Fellows and Junior Faculty Awards
    • Grants
  • About
    PES
    • About PES
      • Contact
      • Leadership
      • PES Committees
      • Society History
    • PES Membership
      • Join PES
    • Partner with Us
      • Mission Alliance Partners
      • Become a Mission Alliance Partner
      • PES Mission Alliance Partner Spotlight
      • Exhibit & Sponsorship Opportunities
      • Mailing List and Advertising
      • Conflict of Interest Statement
    • Policies and Strategy
      • Equity, Diversity and Inclusion Initiative
      • Strategic Plan
      • Policies and Bylaws
      • Public Policy and Advocacy
  • Join PES
  • Contact
  • Find a Pediatric Endocrinologist
  • Contact
  • Join PES

Learn More About PES!

Contact Us

© 2023 Pediatric Endocrine Society     Privacy Policy     Accessibility Statement

Website by Yoko Co

Scroll To Top